Study of FCN-098 in Patients With Advanced Solid Tumor
NCT05212987
·
clinicaltrials.gov ↗
PHASE1
Phase
UNKNOWN
Status
43
Enrollment
INDUSTRY
Sponsor class
Conditions
Solid Tumor
Interventions
DRUG:
FCN-098
Sponsor
Fochon Pharmaceuticals, Ltd.